Skip to main content
Premium Trial:

Request an Annual Quote

'Removal of Evil Spirits…Not Included'

Derek Lowe at In the Pipeline blogs about an online auction of "assets" from Pfizer, KV Pharmaceutical, and Universal MS Services, LLP, including mass spectrometers, assorted high performance liquid chromatography components, liquid-handling systems, tablet presses, and more — all derivatives of the "complete closure of state-of-the-art laboratories." Lowe writes, "Don't let the fact that a massive drug company had no need for all this equipment put you off," adding that the "removal of evil spirits is, as far as I can tell, not included."

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.